12-methylbenzanthracene has been researched along with Experimental Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buhler, DR; Chang, RL; Conney, AH; Jerina, DM; Levin, W; Newman, MS; O'Malley, RF; Slaga, TJ; Wood, AW | 1 |
Bohuon, C; Pallardy, M; Saas, P | 1 |
2 other study(ies) available for 12-methylbenzanthracene and Experimental Neoplasms
Article | Year |
---|---|
Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Carcinogens; Cocarcinogenesis; Female; Hydrocarbons, Fluorinated; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Time Factors | 1982 |
Effects of methyl substitutions on benz[a]anthracene derivatives-induced immunosuppression.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibodies, Monoclonal; Benz(a)Anthracenes; Carcinogens; CD3 Complex; Cell Cycle; Cell Division; Concanavalin A; Female; Immunosuppressive Agents; Interleukin-1; Interleukin-2; Interleukin-6; Lethal Dose 50; Methylation; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Receptors, Interleukin-2; Signal Transduction; Spleen; Structure-Activity Relationship; T-Lymphocytes | 1996 |